Upregulated tear uric acid and IL‐1β levels identified in the eyes of hyperuricemia patients imply IL‐1β‐mediated inflammation may be a plausible mechanism underlying hyperuricemia and gout‐associated ocular symptoms. This evidence concerns the gene IL1B and gout.